57-83-0 | Sigma-Aldrich

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

IPI00022229 Apolipoprotein B-100 precursor 78 2 64 1 747 23 IPI00017601 Ceruloplasmin precursor 83 2 170 4 50 1 122 3 241 8 434 13 IPI00783987 Complement C3 precursor 716 18 74 2 804 16 77 2 886

Product Information Sheet - N0788

49 50 51 52 53 54 55 56 57 58 59 60 Negative siRNA control (30 nM) F 61 62 63 64 65 66 67 68 69 70 71 72 siRNA only control (30 nM) G

Protocol: Human Ghrelin (Active)

0% Canine Ghrelin (Active) 106% Porcine Ghrelin (Active) 57% Motilin Related Peptide (Human, Rat/Mouse) 0% PYY 3~36 (Human, Mouse

Amicon® Ultra-2 Centrifugal Filter Devices for volumes up to 2 mL

Rotor 0 0.5 1 1.5 2 0 10 20 30 40 50 60 3K 10K 30K 50K 100K Fi ltr at e Vo lu m e

Amicon® Ultra-2 Centrifugal Filter Devices User Guide

Recovery (%) PCR Primer Removal (%) Final Volume (μL) 137 10 20 48 83 87 86 92 80 61 44 43 41 78 75

An Update on Ligands for Prostanoid Receptors

is si o n s Vo l 2 0, N o. 2 , 20 04 O rd er : 1- 80 0- 32 5- 30 10 Te ch ni ca

Advanced Applications of Engineered Nanomaterials

oxide 25-30 nanopowder 5��7�0 Zirconium(IV) oxide 0�5 Zirconium silicate 25-30 nanopowder 5��7�0 41 Nb Niobium 99+ % 100 nanopowder 59��57 42 Mo Molybdenum, activated

HUMAN INSULIN SPECIFIC RIA KIT

25 µl 36 86 3 100 µl 62 62 100 75 µl 59 95 50 µl 57 92 25

Antibiotics and Antimycotics

62-63 S: 22-36/37 Spectinomycin dihydrochloride hydrate 5 g 25 g S 9007 E CAS No. 21736-83-4 C14H24N2O7 � 2HCl FW 405.3 Mode of Action: Inhibits protein synthesis (elongation) by interfering

Accu-Jet Pro Pipette Controller Manual

sécutité 52 Fonction et limites d'emploi 54 Eléments de commande 56 Premiers pas 57 Mis en service 57 Support mural · rangement sur table 58 Fonctions de pipetage 59 Pipetage 60 Recharge

User Guide - Z756997

........................ 83 13.1 Cleaning .................................................................................................................................. 83 13.2 Service, maintenance

Protocol: Rat/ Mouse Insulin ELISA Kit

Serum # 1 0 0.33 -- 0.5 0.83 100 2 2.15 91 5 5.07 95 Mouse Serum # 2 0 1.78 --

Protein Tyrosine Phosphatases- Potential Roles in Disease

d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 ( U S ) T e c h n i c a l S

MILLIPLEX® MAP 384-Well High Sensitivity Human Cytokine Magnetic Bead Panel

94 IL-1β 94 IL-2 91 IL-21 94 IL-4 90 IL-23 90 IL-5 88 IL-6 79 IL-7 83 IL-8 91 MIP-1α

CIX001 Plate Map

)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C1CCCCC1 C27H41N5O4 CIX-01330861-A 2720555-83-7 0.125 499.656 499.656 consistent with structure C 9 Single stereoisomer CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1

Evaluation of MultiScreen-MIC Plates in Invasion and Angiogenesis Assays

3 Lot 1 Lot 2 Lot 3 Lot 1 Lot 2 Lot 1 Lot 2 Percent inhibition of invasion 61 78 79 47 31 36 83 90 32 40 1 plate per lot, with 14 replicates per plate

Protocol- HMH3-34K

3 25 1,852 1,235 185 9 Standard 4 74 5,556 3,704 556 28 Standard 5 222 16,667 11,111 1,667 83 Standard 6 667 50,000 33,333 5,000 250 Standard 7 2,000 150,000 100,000

Human Metabolic Hormone Panel V3

3 25 1,852 1,235 185 9 Standard 4 74 5,556 3,704 556 28 Standard 5 222 16,667 11,111 1,667 83 Standard 6 667 50,000 33,333 5,000 250 Standard 7 2,000 150,000 100,000

Protocol- HCD8MAG-15K

Granzyme A 90 IL-13 88 Granzyme B 88 sFas 88 IL-2 89 IL-4 90 IL-5 93 IL-6 83 sFasL 87 MIP-1α 90

Protocol - RMHE-120K

Ghrelin (Active) 1.6 2.9 83% GLP-1 Total 10.5 22.4 <10 <20 92% Glucagon 4.0 6.0 <10 <20 95% IL-6 36.0 116.1 <10 <20

Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation

B Flow µL/min 0 15 85 760 0.8 15 85 760 4 100 0 500 5 100 0 500 6 15 85 500 Time (min) %A %B Flow µL/min 0 17 83 760 0.4 17 83 760 4 100 0 500 5

User Manual

following topics: Topic See Page Alert information 83 Summary of Alert messages 88 Milli-Q® Reference System 83

Analytix Reporter Issue 11 2022

-52-8 2.5 mmol/L L-Lysine13C6 55443-57-7 2.5 mmol/L L-Methionine13C5, 15N 202468-47-1 2.5 mmol/L L-Phenyl-13C6-alanine 180268-82-0 2.5 mmol/L L-Proline-13C5 201740-83-2 2.5 mmol/L L-Serine-13C3, 15N 202407

APC SmartTouch Manual

CGA Technical Specifications 81 Adding New Printer Paper 82 Maintenance 83 Maintenance and calibration Schedule 83 Troubleshooting 84 Contacting Customer Service 85 Appendix A Specifications

Olefin Metathesis Application Guide

40 – 60°C CH2Cl2, 40°C(CH2)12CH3 O O Ph (CH2)12CH3 Ph O O68% OAc O 83% OAc O neat, 80 ºC, 2 h 33 mbar 2 2

Material Matters Volume 1 Number 3 - Deposition of Ceramic and Hybrid Materials

. O r d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 T e c h n i c a l S e r v

Amidine-Based Catalysts (ABCs)- Design Development and Applications

dr = 80:20 to 98:2 83–99% ee Ar2 Ar1 OH O Ar3 NTs NTs O Ar1 Ar2 Ar3 + R = CO2Me, CO2Et, CO2i-Pr (c) PivCl (1.75 equiv) i-Pr2NEt (2.0 equiv) CH2Cl2, 0 oC–rt, 2 h

Operating Manual Spectroquant® Colorimeter Move DC

accuracy 1 .000 Abs + 0 .030 Abs 2 .600 Abs + 0 .078 Abs (^= 3 % FS) (measured with standard solutions - T = 20 - 25 °C) FS = full scale

59505 Galactosyltransferase Kit

. Beyer, et al., Adv. Enzymol., 1981, 52, 24. 29 J.E. Sadler, et al., Method. Enzymol., 1982, 83, 458. 30 M.J. Morin, et al., J. Biochem. Pharm., 1983, 32, 553. 31 W. McDowell, et

Transferpette S Pipette Manual

7056 81 7034 91 7033 43 10 - 100 µl 7056 62 7056 82 7034 91 7033 44 20 - 200 µl 7056 63 7056 83 7034 91 7033 45 30 - 300 µl